OWD
TAK icon

Osborn Williams & Donohoe’s Takeda Pharmaceutical TAK Stock Holding History

Osborn Williams & Donohoe’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$1.08M Hold
71,430
– – 0.14% 131
2019
Q4 		$1.41M Sell
71,430
-65,031
-48% -$1.24M 0.14% 139
2019
Q3 		$2.35M Hold
136,461
– – 0.24% 105
2019
Q2 		$2.42M Sell
136,461
-671
-0.5% -$12.2K 0.25% 107
2019
Q1 		$2.68M Buy
+137,132
New +$2.76M 0.28% 100

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osborn Williams & Donohoe's TAK Position: Q1 2020 in Review

Osborn Williams & Donohoe held its Takeda Pharmaceutical (TAK) position steady in Q1 2020 at 71,430 shares worth $1.08M. The position accounts for 0.14% of the portfolio, ranked #131.

Osborn Williams & Donohoe first reported a position in TAK in Q1 2019 and has held it in 5 quarters since. The position peaked at $2.68M in Q1 2019. 312 funds tracked by Wall St. Rank hold TAK as of Q1 2020.

  • Osborn Williams & Donohoe held 71,430 shares of Takeda Pharmaceutical worth $1.08M as of Q1 2020.
  • Osborn Williams & Donohoe left its Takeda Pharmaceutical share count unchanged in Q1 2020.
  • Takeda Pharmaceutical made up 0.14% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #131 holding.
  • Osborn Williams & Donohoe first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 5 quarters since.
  • Osborn Williams & Donohoe's Takeda Pharmaceutical position peaked at $2.68M in Q1 2019.
  • 312 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.